1435
An interesting session with a good group interaction, good examples/reflections, to trigger people prior to the training, using different methods to make it interactive.
C02
Obtained a global overview of the involvement of PM over the whole course of a project/clinical trial which allowed me to bridge theory into practice. Very good balance and through this, it increased the amount of information I had on these topics. Very good global on what PM includes with very useful hands-on tips.
1551
I got a good understanding on the the difference between the complex an different definitions of mRECIST/irRECIST and iRECIST because of the openness of the group and the expertise of the trainer that replied to all questions allowing it to be interactive and adapted to the group needs.
1546
Got a good overall view on clinical trials oversight, received excellent tips about some documentation practices. The materials given were crucial and learned much with the real life discussions during the training.
B01
My objectives such as prepare department policy changes to adapt upcoming changes in regulations were achieved through the updates discussed on relevant regulations (e.g. CTR and MDR) and the great interaction and time to debate over the questions risen during the training.
C05
It's a good introductory course on the regulatory requirements concerning clinical trials; not only letting you know what they are, but also why they are needed and how they came to existence.
C29
This course provided a nice general overview of project management systems which allowed me to gain more knowledge about it. Through this course I will be able to put into practice Budgeting and budget monitoring.
C29
I got a systematic overview of topics relevant for a senior CPM position with a special focus on patient’s perspective. The classroom was made in an ideal way to allow us to discuss and exchange ideas.
C29
The course was really great and the teachers were excellent allowing a good interexchange between participants with different professional experiences and backgrounds. This interaction was very beneficial. Thank you for this opportunity to learn.
B02
The course offers a very good introduction to Risk Management in clinical trials. It is a great advantage that all participants are at the same level of knowledge at the beginning of the face-to-face-training due to the eLearning session that has to be completed in advance. I liked the combination of theory and workshops, which resulted
